Adam D. Scott - Publications

Affiliations: 
Washington University, Saint Louis, St. Louis, MO 
Area:
phase transitions, evolution, cancer

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Scott AD, King DM, Ordway SW, Bahar S. Phase transitions in evolutionary dynamics. Chaos (Woodbury, N.Y.). 32: 122101. PMID 36587338 DOI: 10.1063/5.0124274  0.624
2021 Huang KL, Scott AD, Zhou DC, Wang LB, Weerasinghe A, Elmas A, Liu R, Wu Y, Wendl MC, Wyczalkowski MA, Baral J, Sengupta S, Lai CW, Ruggles K, Payne SH, et al. Spatially interacting phosphorylation sites and mutations in cancer. Nature Communications. 12: 2313. PMID 33875650 DOI: 10.1038/s41467-021-22481-w  0.641
2019 Huang KL, Wu Y, Primeau T, Wang YT, Gao Y, McMichael JF, Scott AD, Cao S, Wendl MC, Johnson KJ, Ruggles K, Held J, Payne SH, Davies SR, Dar A, et al. Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability. Molecular & Cellular Proteomics : McP. PMID 31196969 DOI: 10.1074/Mcp.Ra118.001243  0.613
2018 Sun SQ, Mashl RJ, Sengupta S, Scott AD, Wang W, Batra P, Wang LB, Wyczalkowski MA, Ding L. Database of evidence for precision oncology portal. Bioinformatics (Oxford, England). 34: 4315-4317. PMID 30535306 DOI: 10.1093/Bioinformatics/Bty531  0.501
2018 Scott AD, Huang KL, Weerasinghe A, Mashl RJ, Gao Q, Martins Rodrigues F, Wyczalkowski M, Ding L. CharGer: Clinical Characterization of Germline Variants. Bioinformatics (Oxford, England). PMID 30102335 DOI: 10.1093/Bioinformatics/Bty649  0.39
2018 Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N, Scott AD, Krassowski M, Cherniack AD, Houlahan KE, Jayasinghe R, et al. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell. 173: 355-370.e14. PMID 29625052 DOI: 10.1016/J.Cell.2018.03.039  0.657
2018 Martins Rodrigues F, Gao Q, Huang K, Scott AD, Foltz SM, King J, Fiala MA, Kohnen DR, DiPersio JF, Vij R, Ding L. Characterization of Germline Variants in Multiple Myeloma Blood. 132: 4499-4499. DOI: 10.1182/Blood-2018-99-118673  0.504
2017 Niu B, Scott AD, Sengupta S, Bailey MH, Batra P, Ning J, Wyczalkowski MA, Liang WW, Zhang Q, D McLellan M, Sun SQ, Tripathi P, Lou C, Ye K, Jay Mashl R, et al. Corrigendum: Protein-structure-guided discovery of functional mutations across 19 cancer types. Nature Genetics. 49: 1286. PMID 28747753 DOI: 10.1038/Ng0817-1286A  0.443
2017 Mashl RJ, Scott AD, Huang KL, Wyczalkowski MA, Yoon CJ, Niu B, DeNardo E, Yellapantula VD, Handsaker RE, Chen K, Koboldt DC, Ye K, Fenyö D, Raphael B, Wendl MC, et al. GenomeVIP: a cloud platform for genomic variant discovery and interpretation. Genome Research. PMID 28522612 DOI: 10.1101/Gr.211656.116  0.6
2017 King DM, Scott AD, Bahar S. Multiple phase transitions in an agent-based evolutionary model with neutral fitness. Royal Society Open Science. 4: 170005. PMID 28484629 DOI: 10.1098/Rsos.170005  0.66
2017 Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, ... ... Scott A, et al. Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nature Communications. 8: 15479. PMID 28440318 DOI: 10.1038/Ncomms15479  0.603
2017 Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, ... ... Scott A, et al. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nature Communications. 8: 14864. PMID 28348404 DOI: 10.1038/Ncomms14864  0.639
2016 Niu B, Scott AD, Sengupta S, Bailey MH, Batra P, Ning J, Wyczalkowski MA, Liang WW, Zhang Q, McLellan MD, Sun SQ, Tripathi P, Lou C, Ye K, Mashl RJ, et al. Protein-structure-guided discovery of functional mutations across 19 cancer types. Nature Genetics. PMID 27294619 DOI: 10.1038/Ng.3586  0.671
2016 Scott AD, Yellapantula VD, Yoon CJ, Wendl M, Tomasson MH, Fiala MA, DiPersio JF, Vij R, Ding L. Uncovering Clonal and Subclonal Druggable Targets in Multiple Myeloma Using Omic Data Blood. 128: 2084-2084. DOI: 10.1182/Blood.V128.22.2084.2084  0.657
2015 Ye K, Wang J, Jayasinghe R, Lameijer EW, McMichael JF, Ning J, McLellan MD, Xie M, Cao S, Yellapantula V, Huang KL, Scott A, Foltz S, Niu B, Johnson KJ, et al. Systematic discovery of complex insertions and deletions in human cancers. Nature Medicine. PMID 26657142 DOI: 10.1038/Nm.4002  0.641
2015 Sengupta S, Ye K, Scott AD, Niu B, Bailey MH, McLellan MD, Wendl MC, Wyczalkowski MA, Ding L. Abstract 61: Sequence and structure-guided approach to identify functional mutations in G-protein coupled receptors Cancer Research. 75: 61-61. DOI: 10.1158/1538-7445.Am2015-61  0.659
2015 Huang K, Wang J, Cao S, Xie M, Jayasinghe R, Ning J, McLellan M, Wendl M, Scott A, Johnson K, Davies S, Fenyö D, Townsend R, Chen F, Parvin J, et al. Abstract 1939: Discovery and proteogenomic investigation of genetic variants in human cancers Cancer Research. 75: 1939-1939. DOI: 10.1158/1538-7445.Am2015-1939  0.661
2013 Scott AD, King DM, Marić N, Bahar S. Clustering and phase transitions on a neutral landscape Epl. 102. DOI: 10.1209/0295-5075/102/68003  0.663
Show low-probability matches.